Literature DB >> 195404

Infectious mononucleosis and mononucleosis syndromes.

M Fiala, D C Heiner, J A Turner, B Rosenbloom, L B Guze.   

Abstract

Infectious mononucleosis (IM) and cytomegalovirus (CMV) mononucleosis are caused by a primary infection with related viruses, Epstein-Barr virus (EBV) and CMV. Despite the similarity of clinical manifestations, basic differences exist: (1) The heterophil antibody (HA) response is absent in CMV mononucleosis, whereas it is present in IM. (2) In IM atypical lymphocytosis reflects proliferation of B cells early and of T cells later in the disease course; in CMV mononucleosis the situation appears complex. (3) In blood, EBV is restricted to B lymphocytes, whereas CMV is found in polymorphonuclear and mononuclear leukocytes. (4) Complications of CMV mononucleosis such as hepatitis and pneumonitis may be due to virus cytopathic effect in target organs. Prominent tonsillopharyngitis with adenopathy, and visceral complications of IM are related to lymphoproliferation which is self-limited except in males with a rare familial defect in defense against EBV. Immune complex-mediated pathology may occur in both diseases. (5) CMV is frequently transmitted to a fetus in utero or to an infant during or after birth, and this occasionally leads to severe cytomegalic inclusion disease; vertical transmission of EBV appears to be exceptional. (6) Secondary EBV infections are associated with certain malignancies whereas such an association has not been recognized in the case of CMV. Toxoplasma gondii is another cause of HA-negative mononucleosis. Its complications in the heart, in skeletal muscle and in the central nervous system are related to direct invasion by the parasite. Cellular immunity plays an important role in defense against all three agents.

Entities:  

Mesh:

Year:  1977        PMID: 195404      PMCID: PMC1237626     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  271 in total

1.  The Epstein-Barr virus and neoplasia.

Authors:  G Klein
Journal:  N Engl J Med       Date:  1975-12-25       Impact factor: 91.245

2.  A prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: Specificity and sensitivity of the tests and persistence of antibody.

Authors:  A S Evans; J C Niederman; L C Cenabre; B West; V A Richards
Journal:  J Infect Dis       Date:  1975-11       Impact factor: 5.226

3.  Cytomegalovirus infection in a volunteer blood donor population.

Authors:  R C Kane; W E Rousseau; G R Noble; G E Tegtmeier; H Wulff; H B Herndon; T D Chin; W L Bayer
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

4.  The specificity of heterophil antibodies in patients and healthy donors with no or minimal signs of infectious mononucleosis.

Authors:  C A Horwitz; W Henle; G Henle; H Polesky; H Wexler; P Ward
Journal:  Blood       Date:  1976-01       Impact factor: 22.113

Review 5.  Infection, anergy and cell-mediated immunity.

Authors:  F S Kantor
Journal:  N Engl J Med       Date:  1975-03-20       Impact factor: 91.245

6.  Cell-mediated immunity to Epstein-Barr-virus-transformed lymphoblastoid cells in acute infectious mononucleosis.

Authors:  I Royston; J L Sullivan; P O Periman; E Perlin
Journal:  N Engl J Med       Date:  1975-12-04       Impact factor: 91.245

7.  Epidemiology of cytomegalovirus infection after transplantation and immunosuppression.

Authors:  M Fiala; J E Payne; T V Berne; T C Moore; W Henle; J Z Montgomerie; S N Chatterjee; L B Guze
Journal:  J Infect Dis       Date:  1975-10       Impact factor: 5.226

8.  Envelope and nucleocapsid antigens of Cytomegalovirus (CMV).

Authors:  H Schmitz; H W Doerr; M Obrig
Journal:  Med Microbiol Immunol       Date:  1975-07-02       Impact factor: 3.402

9.  Direct visualization of enveloped Epstein-Barr Herpesvirus in throat washing with leukocyte-transforming activity.

Authors:  M Lipman; L Andrews; J Niederman; G Miller
Journal:  J Infect Dis       Date:  1975-11       Impact factor: 5.226

10.  Probable identification of an HL-A second-locus antigen associated with a high risk of nasopharyngeal carcinoma.

Authors:  M J Simons; G B Wee; S H Chan; K Shanmugaratnam
Journal:  Lancet       Date:  1975-01-18       Impact factor: 79.321

View more
  5 in total

1.  Infectious mononucleosis.

Authors:  M A Papadakis
Journal:  West J Med       Date:  1982-08

2.  Fever of undetermined origin: role of cytomegalovirus and Epstein-Barr virus.

Authors:  M Fiala; S Chatterjee; R Ellis; B Imparato; S Bahna; A Saxon
Journal:  West J Med       Date:  1978-10

Review 3.  Cytomegalovirus Hepatitis in Immunocompetent and Immunocompromised Hosts.

Authors:  Teresa Da Cunha; George Y Wu
Journal:  J Clin Transl Hepatol       Date:  2021-01-04

4.  Case Report: Cytomegalovirus Reactivation and Pericarditis Following ChAdOx1 nCoV-19 Vaccination Against SARS-CoV-2.

Authors:  Marlene Plüß; Kemal Mese; Johannes T Kowallick; Andreas Schuster; Désirée Tampe; Björn Tampe
Journal:  Front Immunol       Date:  2022-01-18       Impact factor: 7.561

5.  Viral metagenomics performed in patients with acute febrile syndrome during Toxoplasma gondii outbreak in south Brazil.

Authors:  Rafael Dos Santos Bezerra; Cristiane Fração Diefenbach; Dalnei Veiga Pereira; Simone Kashima; Svetoslav Nanev Slavov
Journal:  Braz J Infect Dis       Date:  2020-05-15       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.